Works matching IS 00099236 AND DT 2013 AND VI 94 AND IP 2
Results: 25
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Overcoming Challenges of Real-World Implementation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 207, doi. 10.1038/clpt.2013.59
- By:
- Publication type:
- Article
Genetics of Cisplatin Ototoxicity: Confirming the Unexplained?
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 198, doi. 10.1038/clpt.2013.116
- By:
- Publication type:
- Article
Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 243, doi. 10.1038/clpt.2013.80
- By:
- Publication type:
- Article
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 176, doi. 10.1038/clpt.2013.113
- Publication type:
- Article
Comparative Effectiveness of Dabigatran, Rivaroxaban, Apixaban, and Warfarin in the Management of Patients With Nonvalvular Atrial Fibrillation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 269, doi. 10.1038/clpt.2013.83
- By:
- Publication type:
- Article
The Role of Inherited TPMT and COMT Genetic Variation in Cisplatin-Induced Ototoxicity in Children With Cancer.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 252, doi. 10.1038/clpt.2013.121
- By:
- Publication type:
- Article
CYP2D6 Genotype and Tamoxifen Activity: Understanding Interstudy Variability in Methodological Quality.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 185, doi. 10.1038/clpt.2013.66
- By:
- Publication type:
- Article
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 167, doi. 10.1038/clpt.2013.124
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 174, doi. 10.1038/clpt.2013.123
- Publication type:
- Article
A Health-Care System Perspective on Implementing Genomic Medicine: Pediatric Acute Lymphoblastic Leukemia as a Paradigm.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 224, doi. 10.1038/clpt.2013.9
- By:
- Publication type:
- Article
CYP2D6 Genotype Should Not Be Used to Determine Endocrine Therapy in Postmenopausal Breast Cancer Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 183, doi. 10.1038/clpt.2013.102
- By:
- Publication type:
- Article
A Physiologically Based Pharmacokinetic Modeling Approach to Predict Disease-Drug Interactions: Suppression of CYP3A by IL-6.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 260, doi. 10.1038/clpt.2013.79
- By:
- Publication type:
- Article
Genomic Testing: The Clinical Laboratory Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 190, doi. 10.1038/clpt.2013.61
- By:
- Publication type:
- Article
Educational Challenges in Implementing Genomic Medicine.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 192, doi. 10.1038/clpt.2013.38
- By:
- Publication type:
- Article
Response to 'CYP3A5 Genotype, but Not CYP3A4*1b, CYP3A4*22, or Hematocrit, Predicts Tacrolimus Dose Requirements in Brazilian Renal Transplant Patients'.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 202, doi. 10.1038/clpt.2013.94
- By:
- Publication type:
- Article
CYP3A5 Genotype, but Not CYP3A4*1b, CYP3A4*22, or Hematocrit, Predicts Tacrolimus Dose Requirements in Brazilian Renal Transplant Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 201, doi. 10.1038/clpt.2013.68
- By:
- Publication type:
- Article
Regulatory and Scientific Issues Regarding Use of Foreign Data in Support of New Drug Applications in the United States: An FDA Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 230, doi. 10.1038/clpt.2013.70
- By:
- Publication type:
- Article
The Opportunities and Challenges of Implementing Genomics-Informed Personalized Medicine.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 181, doi. 10.1038/clpt.2013.71
- By:
- Publication type:
- Article
Genomic Medicine, Precision Medicine, Personalized Medicine: What's in a Name?
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 169, doi. 10.1038/clpt.2013.101
- By:
- Publication type:
- Article
A Systematic Approach to the Development of Novel Therapeutics for Lung Cancer Using Genomic Analyses.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 218, doi. 10.1038/clpt.2013.90
- By:
- Publication type:
- Article
The CLIPMERGE PGx Program: Clinical Implementation of Personalized Medicine Through Electronic Health Records and Genomics-Pharmacogenomics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 214, doi. 10.1038/clpt.2013.72
- By:
- Publication type:
- Article
Regulatory Challenges in the Review of Data from Global Clinical Trials: The PMDA Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 195, doi. 10.1038/clpt.2013.106
- By:
- Publication type:
- Article
Challenges in Implementing Genomic Medicine: The Mayo Clinic Center for Individualized Medicine.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 204, doi. 10.1038/clpt.2013.52
- By:
- Publication type:
- Article
Challenges in the Pharmacogenomic Annotation of Whole Genomes.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 211, doi. 10.1038/clpt.2013.111
- By:
- Publication type:
- Article
Genomic Medicine: Too Great Expectations?
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 188, doi. 10.1038/clpt.2013.44
- By:
- Publication type:
- Article